bpc 157 and sibo BPC-157 – Mark Hyman, MD SIBO: Causes, Personalized Treatment, and

Conventional Antiarrhythmics Class I-IV, Late INa Inhibitors, IKs Enhancers, RyR2 Stabilizers, Gap Junction Modulators, Atrial-Selective Antiarrhythmics, and Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Therapy in Arrhythmias

Units assume a U100 insulin syringe (100 units = 1 mL on U-100)

Explanation is provided as under: Chemical Synthesis (For Vitamin B1 and B6) Chemical synthesis is a method where specific chemical compounds are selected to form vitamin b1 and b6 molecules

Early treatment can help prevent nerve damage from B12 deficiency

This form is used in most animal studies and preclinical trials and is favored by clinicians and experienced biohackers for its high bioavailability, systemic distribution, and targeted healing capacity